Thiazole derivatives having vap-1 inhibitory activity

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/46 (2006.01) A61K 31/426 (2006.01)

Patent

CA 2575411

A compound of the formula (I), (II), (III) or (IV): wherein each symbol is as defined in the specification,or a pharmaceutically acceptable salt thereof useful as a vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, a method for preventing or treating a VAP-1 associated disease, especially macular edema, which method includes administering an effective amount of the compound or a pharmaceutically acceptable salt thereof to a subject, and the like.

L'invention concerne un composé de formule (I), (II), (III) ou (IV), dans lesquelles chaque symbole est spécifié dans la description, ou un de ses sels pharmaceutiquement acceptables, utilisés en tant qu'inhibiteur (VAP-1) de la protéine 1 d'adhésion vasculaire, une composition pharmaceutique, et un procédé pour prévenir ou traiter une maladie associée à la VAP-1, en particulier un oedème maculaire. Ledit procédé comprend l'administration d'une quantité efficace du composé ou d'un de ses sels pharmaceutiquement acceptable à un sujet, et analogues.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Thiazole derivatives having vap-1 inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazole derivatives having vap-1 inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole derivatives having vap-1 inhibitory activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1428927

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.